期刊文献+

圣约翰草提取物治疗女性更年期抑郁症对照研究 被引量:3

A comparative study about efficiency of StJohn's wort extract in the treatment of female patients with involutional depression
下载PDF
导出
摘要 目的评价圣约翰草提取物治疗女性更年期抑郁症患者的疗效及安全性。方法 64例更年期抑郁症患者随机分为研究组32例及对照组32例,分别服用圣约翰草提取物和帕罗西汀,疗程均为6周。基线时及治疗后第2、4、6周末采用临床总体评定量表(CGI),汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、不良反应量表(TESS)评价疗效和安全性。结果研究组有效率为81.25%,对照组有效率为84.38%,两组之间差异无统计学意义(P>0.05)。两组HAMD评分值与HAMA评分值从第2周末开始,较基线值比较差异均有统计学意义(P<0.01)。两组之间比较,差异无统计学意义(P>0.05)。两组不良反应较轻,但治疗后第6周末,研究组TESS评分值低于对照组,其差异有统计学意义(P<0.05)。结论圣约翰草提取物治疗更年期抑郁症有较好疗效,不良反应轻,安全性高。 Objective To investigate the efficiency and safety of St. John's wort extract in the treatment of female patients with involutional depression. Methods A total of 64 female patients with involutional depression were randomly divided into study group treated with St. John's wort extract and control group treated with paroxetine for 6 weeks. Efficiency and safety were assessed with Clinical Global Impressions (CGI) , the 24 -item Hamilton Depression Rating Scale (HAMD -24 ), Hamilton Anxiety Rating Scale (HAMA), Treatment Emergent Symptom Scale (TESS) at the baseline, the 2nd weekend, 4th weekend and 6th weekend after treatment. Results There was no significant difference in the effective rate between study group and control group ( 81.25% vs. 84.38% , P 〉 0.05 ). Compared with the baseline, total scores of HAMD and HAMA in the two groups decreased significantly from the 2nd weekend ( P 〈0.01 ). There were no significant differences in total scores of HAMD and HAMA between the two groups at each interview - point ( P 〉 0.05 ). Side effects were few in both of the groups, but the score of TESS in study group was significantly lower than that in control group ( P 〈 0.05 ). Conclusion St. John wort extract is effective for the treatment of involutional depressive with less side effects and high safety.
出处 《精神医学杂志》 2011年第2期106-108,共3页 Journal of Psychiatry
关键词 圣约翰草提取物 帕罗西汀 更年期抑郁症 St. John wort extract Paroxetine Involutional depression
  • 相关文献

参考文献11

  • 1Schulte - L~bbert S, Holoubek G, Mfiller WE, et al. Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products [ J]. J Pharm Pharmaeo1,2004,56 (6) : 813 - 818.
  • 2Carlo GD, Borrelli F, Ernst E. St John's wort:Prozac from theplant kingdom [ J ]. Trends in Pharmacological Sciences, 2001, 22 (6) : 292 - 297.
  • 3Lecrubier Y, Clerc G, Didi R, et al. Efficacy of St. John' s Wort Extract WS 5570 in Major Depression: A Double - Blind, Placebo - Controlled Trial [ J ]. Am J Psychiatry, 2002, 159 : 1361 - 1366.
  • 4Meyer JH, Kennedy S, Brown G, et al. No effect of depression on [ 15 O ] H20 PET response to intravenous d - fenfluramine [ J ]. Am J Psychiatry, 1998,155 : 1241 - 1246.
  • 5Gilmor ML, Owens M J, Nemeroff CB. Inhibition of norepinephrine uptake in patients with major depression treated with faroxetine [ J ]. Am J Psychiatry,2002,159 : 1702 - 1710.
  • 6张巍,郭锡永,刘景英.更年期妇女抑郁症状与血清孕激素、叶酸、五羟色胺的相关性研究[J].中国妇幼保健,2006,21(17):2433-2436. 被引量:15
  • 7Harrer G, Htibner WD, Podzuweit H. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a muhicenter double - blind study [ J ]. J Geriatric Psychiatry Neurol, 1994,7 ( suppl 1 ) :24 - 28.
  • 8Philipp M, Kohnen R, Hiller KO. Hyperieum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks [ J ]. BMJ, 1999,319 : 1534 - 1538.
  • 9Vorbach EU, Htibner WD, Arnoldt KH. Effectiveness and tolerance of the hypericum extract LI 160 in comparison with imipramine: randomized double -blind study with 135 outpatients [ J ]. J Geriatric Psychiatry Neurol, 1994,7 ( suppl 1) :19 -23.
  • 10Wheatley D. LI 160, an extract of St. John "s wort, versus amitriptyline in mildly to moderately depressed outpatientsa controlled 6 - week clinical trim [ J ]. Pharmacopsychiatry, 1997,30( suppl 2) :77 - 80.

二级参考文献20

  • 1Illanes E,Bustos L,Lagos X et al.Associated factors to depressive symptoms and somatic symptoms in climacteric women in the city Temuco.Rev Med Chil,2002,130 (8):885
  • 2Neill Epperson,MD,Katherine L.Wisner,MD.Gonadal Steroids in the Treatment of Mood Disorders,Psychosomatic Medicine,1999,61:676
  • 3Meir Steiner,Edward Dunn,Leslie Born.Hormones and mood:from nenarche to menopause and beyond.J Affe Diso,2003,74:67
  • 4Sherwin BB.Progestogens used in menopause.Side effects,mood and quality of life.J Reprod Med,1999,44 (2 Suppl):227
  • 5Tracey J.Shors,Benedelta Leuner.Estrogen-mediated effects on depression and memory formation in females.J Affe Disor,2003,74:85
  • 6Rajewska J,Rybakowski JK.Depression in premenopausal women:gonadal hormones and serotonergic system assessed by D-fenfluramine chanllenge test.Prog Neuropsych-opharmacol Biol Psychiatry,2003,27 (4):705
  • 7Bjorn I,Sundstrom-Poromaa I,Bixo M et al.Increase of estrgen dose deteriorates mood during progestin phase in sequential therapy.J Clin Endocrinol Metab,2003,88 (5):2026
  • 8Alpert M,Silva RR,Pouget ER.Prediction of treatment response in geriatric depression from baseline folate level:interaction with an SSRI or a tricyclic antidepressant.J Clin Psychoparmacol,2003,23 (3):309
  • 9Fava M,Borus,JS,Alpert JE et al.Folate,vitamim B12,and homocysteine in major depressive disorder.Am J Psychiatry,1997,154(30):426
  • 10Tolmunen T,Hintikka J,Ruusunen A.Dietary folate and the risk of depression in finnish middle-aged men.A prospective follow-up study.Psychother Psychosom.2004,73 (6):334

共引文献14

同被引文献25

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部